PURPOSE: Higher serum levels of the main circulating form of vitamin D, 25-hydroxyvitamin
D (25 (OH) D), are associated with substantially lower incidence rates of colon, breast …

There has been substantial enthusiasm recently regarding the potential role of vitamin D in
the primary and secondary prevention of cancer. Laboratory studies demonstrate a range of …

In vitro and animal studies indicate that vitamin D may have anti-cancer benefits, including
against progression and metastasis, against a wide spectrum of cancers. Supporting an anti …

An inverse association between serum 25-hydroxyvitamin D [25 (OH) D], and risk of cancers
of the colon, breast, and ovary has been reported in wellconducted observational studies. 1 …

This article is a narrative review of recent epidemiological findings regarding ultraviolet-B
(UVB) dose or exposure, serum 25-hydroxyvitamin D [25 (OH) D] concentrations, vitamin D …

Background: Studies indicate that intake of vitamin D in the range from 1,100 to 4,000 IU/d
and a serum 25-hydroxyvitamin D concentration [25 (OH) D] from 60-80 ng/ml may be …

Any benefit of vitamin D needs to be balanced against the risk of toxicity, which is
characterized by hypercalcemia. Daily brief, suberythemal exposure of a substantial area of …

PURPOSE: To review the history of vitamin D and its use in cancer prevention. METHODS:
The literature on published studies of vitamin D and its role in human health was reviewed …

Over the past two decades, the question of whether vitamin D has a role in cancer incidence,
progression, and mortality has been studied in detail. Colorectal, breast, and prostate …

Considerable preclinical and epidemiologic data suggest that vitamin D may play a role in
the pathogenesis, progression, and therapy for cancer. Numerous epidemiologic studies …